Avandia

Lawyers Helping Avandia Clients

In May 2007, the Food and Drug Administration (FDA) issued a safety alert on diabetes drug Avandia after studies found a potentially significant increased rate of heart-related deaths among patients taking the diabetes drug.

Avandia was approved in 1999 for treatment of type 2 diabetes. Since the drug was approved, FDA has monitored heart-related side effects. Some of these side effects included edema and congestive heart failure. In 2006, the most recent labeling change for Avandia for the first time added a new warning about a potential increase in heart attacks and heart-related chest pain in some individuals using Avandia.

The New England Journal of Medicine reports studies showing up to a 43% increase in heart attacks and other heart problems in people using Avandia.

In November 2007, the FDA added a boxed warning to the Avandia label.  The warning alerts patients and doctors that the drug may increase a patient's risk of heart attack and angina heart-related chest pain.

Patients who are taking Avandia, particularly those who have underlying heart conditions, should contact their doctor about this new information to determine the proper course of treatment.

If you have suffered an injury after taking Avandia, contact Cellino & Barnes at 1-800-621-2020 or contact us.